Replies to post #2146 on Akers Biosciences Inc. (AKER)

[knuts4oe]

Oops, forgot to mention that in 2021's 1st quarter one of the studies scheduled to begin involves dosing with MYMD-1, post Covid 19 patients who have developed depression, when they previously had not had a problem with it.